Phthalocyanine fluorescence in tumors during PDT

Photochem Photobiol. 1990 Mar;51(3):379-81. doi: 10.1111/j.1751-1097.1990.tb01726.x.

Abstract

Athymic nude mice with human tumors transplanted to one of the hind legs were given aluminium phthalocyanine disulfonate (AlPcS2) intraperitoneally. Twenty-four hours after the injection the mice were placed with the tumor in the sample position in a fluorescence spectrometer with modulated excitation. Exposure of the tumors to laser light at a fluence rate of 50-200 mW/cm2 led to a rapid transient reduction by up to 50% of the phthalocyanine fluorescence of the tumor. After the laser irradiation the fluence rate of the fluorescence increased almost up to the initial value within a few minutes. This finding should be taken into account when optimal fluence rates and dose fractionation schemes are sought for photodynamic therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Female
  • Humans
  • Indoles / analysis*
  • Indoles / therapeutic use*
  • Isoindoles
  • Melanoma / drug therapy*
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Organometallic Compounds / therapeutic use*
  • Photochemotherapy*
  • Pigments, Biological / analysis*
  • Radiation-Sensitizing Agents / therapeutic use*
  • Spectrometry, Fluorescence
  • Transplantation, Heterologous

Substances

  • Indoles
  • Isoindoles
  • Organometallic Compounds
  • Pigments, Biological
  • Radiation-Sensitizing Agents
  • aluminum phthalocyanine disulfonate
  • phthalocyanine